Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

GITR (human) monoclonal antibody (Elo-1)

ALX-804-825-C100 100 µg 371.00 USD
Do you need bulk/larger quantities?

Product Details

Alternative Name:Glucocorticoid-induced TNFR-related protein, AITR, Activation-inducible TNFR family receptor, TNFRSF 18
Immunogen:Recombinant human GITR (AITR) extracellular domain (aa 26-161) (Prod. No. ALX-522-061).
UniProt ID:Q9Y5U5
Source:Purified from concentrated hybridoma tissue culture supernatant.
Species reactivity:Human
Applications:Flow Cytometry
Recommended Dilutions/Conditions:Flow Cytometry (1:1,000)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
Application Notes:Not suitable for Immunoprecipitation or Western Blot.
Formulation:Liquid. In PBS containing 0.02% sodium azide.
Use/Stability:Stable for at least 1 year after receipt when stored at -20°C.
Handling:For long term storage, aliquot and freeze at -20°C. Avoid freeze/thaw cycles.
Shipping:Shipped on Blue Ice
Short Term Storage:+4°C
Regulatory Status:RUO - Research Use Only

General Literature References

Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells: F. Kanamaru, et al.; J. Immunol. 172, 7306 (2004), Abstract;
GITR activation induces an opposite effect on alloreactive CD4(+) and CD8(+) T cells in graft-versus-host disease: S.J. Muriglan, et al.; J. Exp. Med. 200, 149 (2004), Abstract;

Related Products

GITR (human):Fc (human), (recombinant) 

Produced in HEK 293 cells. The cysteine-rich region of human GITR (AITR) (aa 26-161) is fused to the Fc portion of human IgG1., ≥90% (SDS-PAGE), ELISA | Print as PDF
ALX-522-061-C050 50 µg 451.00 USD
Do you need bulk/larger quantities?

Product Toolbox


Certificate of Analysis


By target:
By biological activity:
GITR Monoclonal antibody
By catalog section:


Technical Service
Customer Service

Recommend this page

Keep in touch

©2021 Enzo Life Sciences, Inc.,